Literature DB >> 20947048

Prognostic value of global MR myocardial perfusion imaging in women with suspected myocardial ischemia and no obstructive coronary disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study.

Mark Doyle1, Nicole Weinberg, Gerald M Pohost, C Noel Bairey Merz, Leslee J Shaw, George Sopko, Anthon Fuisz, William J Rogers, Edward G Walsh, B Delia Johnson, Barry L Sharaf, Carl J Pepine, Sunil Mankad, Steven E Reis, Diane A Vido, Geetha Rayarao, Vera Bittner, Lindsey Tauxe, Marian B Olson, Sheryl F Kelsey, Robert W W Biederman.   

Abstract

OBJECTIVES: The purpose of this study was to assess the prognostic value of global magnetic resonance (MR) myocardial perfusion imaging (MPI) in women with suspected myocardial ischemia and no obstructive (stenosis <50%) coronary artery disease (CAD).
BACKGROUND: The prognostic value of global MR-MPI in women without obstructive CAD remains unknown.
METHODS: Women (n = 100, mean age 57 ± 11 years, age range 31 to 76 years), with symptoms of myocardial ischemia and with no obstructive CAD, as assessed by coronary angiography, underwent MR-MPI and standard functional assessment. During follow-up (34 ± 16 months), time to first adverse event (death, myocardial infarction, or hospitalization for worsening anginal symptoms) was analyzed using global MPI and left ventricular ejection fraction (EF) data.
RESULTS: Adverse events occurred in 23 (23%) women. Using univariable Cox proportional hazards regression modeling, variables found to be predictive of adverse events were global MR-MPI average uptake slope (p < 0.05), the ratio of MR-MPI peak signal amplitude to uptake slope (p < 0.05), and EF (p < 0.05). Two multivariable Cox models were formed, 1 using variables that were performance site dependent: ratio of MR-MPI peak amplitude to uptake slope together with EF (chi square: 13, p < 0.005); and a model using variables that were performance site independent: MR-MPI slope and EF (chi square: 12, p < 0.005). Each of the 2 multivariable models remained predictive of adverse events after adjustment for age, disease history, and Framingham risk score. For each of the Cox models, patients were categorized as high risk if they were in the upper quartile of the model and as not high risk otherwise. Kaplan-Meier analysis of time to event was performed for high risk versus not high risk for site-dependent (log rank: 15.2, p < 0.001) and site-independent (log rank: 13.0, p < 001) models.
CONCLUSIONS: Among women with suspected myocardial ischemia and no obstructive CAD, MR-MPI-determined global measurements of normalized uptake slope and peak signal uptake, together with global functional assessment of EF, appear to predict prognosis.
Copyright © 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20947048      PMCID: PMC3278772          DOI: 10.1016/j.jcmg.2010.07.008

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN: 1876-7591


  22 in total

1.  Is subendocardial ischaemia present in patients with chest pain and normal coronary angiograms? A cardiovascular MR study.

Authors:  Ilse A C Vermeltfoort; Olga Bondarenko; Pieter G H M Raijmakers; Diego A M Odekerken; Aaf F M Kuijper; Anton Zwijnenburg; Mary J E van der Vis-Melsen; Jos W R Twisk; Aernout M Beek; Gerrit J J Teule; Albert C van Rossum
Journal:  Eur Heart J       Date:  2007-05-15       Impact factor: 29.983

2.  Perfusion abnormality, normal coronaries, and chest pain.

Authors:  Dudley J Pennell
Journal:  J Am Coll Cardiol       Date:  2008-01-29       Impact factor: 24.094

3.  Coronary flow velocity response to adenosine characterizes coronary microvascular function in women with chest pain and no obstructive coronary disease. Results from the pilot phase of the Women's Ischemia Syndrome Evaluation (WISE) study.

Authors:  S E Reis; R Holubkov; J S Lee; B Sharaf; N Reichek; W J Rogers; E G Walsh; A R Fuisz; R Kerensky; K M Detre; G Sopko; C J Pepine
Journal:  J Am Coll Cardiol       Date:  1999-05       Impact factor: 24.094

4.  Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease: Consensus statement from the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association.

Authors:  Jennifer H Mieres; Leslee J Shaw; Andrew Arai; Matthew J Budoff; Scott D Flamm; W Gregory Hundley; Thomas H Marwick; Lori Mosca; Ayan R Patel; Miguel A Quinones; Rita F Redberg; Kathryn A Taubert; Allen J Taylor; Gregory S Thomas; Nanette K Wenger
Journal:  Circulation       Date:  2005-02-01       Impact factor: 29.690

Review 5.  Some thoughts on the vasculopathy of women with ischemic heart disease.

Authors:  Carl J Pepine; Richard A Kerensky; Charles R Lambert; Karen M Smith; Gregory O von Mering; George Sopko; C Noel Bairey Merz
Journal:  J Am Coll Cardiol       Date:  2006-02-07       Impact factor: 24.094

Review 6.  Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies.

Authors:  Leslee J Shaw; C Noel Bairey Merz; Carl J Pepine; Steven E Reis; Vera Bittner; Sheryl F Kelsey; Marian Olson; B Delia Johnson; Sunil Mankad; Barry L Sharaf; William J Rogers; Timothy R Wessel; Christopher B Arant; Gerald M Pohost; Amir Lerman; Arshed A Quyyumi; George Sopko
Journal:  J Am Coll Cardiol       Date:  2006-02-07       Impact factor: 24.094

7.  Sex-based differences in early mortality after myocardial infarction. National Registry of Myocardial Infarction 2 Participants.

Authors:  V Vaccarino; L Parsons; N R Every; H V Barron; H M Krumholz
Journal:  N Engl J Med       Date:  1999-07-22       Impact factor: 91.245

Review 8.  Current evidence on diagnostic testing in women with suspected coronary artery disease: choosing the appropriate test.

Authors:  L J Shaw; R Hachamovitch; R F Redberg
Journal:  Cardiol Rev       Date:  2000 Jan-Feb       Impact factor: 2.644

9.  Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).

Authors:  B Delia Johnson; Leslee J Shaw; Steven D Buchthal; C Noel Bairey Merz; Hee-Won Kim; Katherine N Scott; Mark Doyle; Marian B Olson; Carl J Pepine; Jan den Hollander; Barry Sharaf; William J Rogers; Sunil Mankad; John R Forder; Sheryl F Kelsey; Gerald M Pohost
Journal:  Circulation       Date:  2004-06-14       Impact factor: 29.690

10.  Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project.

Authors:  Martha Gulati; Rhonda M Cooper-DeHoff; Candace McClure; B Delia Johnson; Leslee J Shaw; Eileen M Handberg; Issam Zineh; Sheryl F Kelsey; Morton F Arnsdorf; Henry R Black; Carl J Pepine; C Noel Bairey Merz
Journal:  Arch Intern Med       Date:  2009-05-11
View more
  43 in total

Review 1.  Emergence of Nonobstructive Coronary Artery Disease: A Woman's Problem and Need for Change in Definition on Angiography.

Authors:  Carl J Pepine; Keith C Ferdinand; Leslee J Shaw; Kelly Ann Light-McGroary; Rashmee U Shah; Martha Gulati; Claire Duvernoy; Mary Norine Walsh; C Noel Bairey Merz
Journal:  J Am Coll Cardiol       Date:  2015-10-27       Impact factor: 24.094

2.  Improved diagnosis and prognosis using Decisions Informed by Combining Entities (DICE): results from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE).

Authors:  Mark Doyle; Gerald M Pohost; C Noel Bairey Merz; Leslee J Shaw; George Sopko; William J Rogers; Barry L Sharaf; Carl J Pepine; Diane A Vido-Thompson; Geetha Rayarao; Lindsey Tauxe; Sheryl F Kelsey; Douglas Mc Nair; Robert W Biederman
Journal:  Cardiovasc Diagn Ther       Date:  2013-12

3.  Inverse association of MRI-derived native myocardial T1 and perfusion reserve index in women with evidence of ischemia and no obstructive CAD: A pilot study.

Authors:  Jaime L Shaw; Michael D Nelson; Janet Wei; Manish Motwani; Sofy Landes; Puja K Mehta; Louise E J Thomson; Daniel S Berman; Debiao Li; C Noel Bairey Merz; Behzad Sharif
Journal:  Int J Cardiol       Date:  2018-06-22       Impact factor: 4.164

4.  Left Ventricular Energy Model Predicts Adverse Events in Women With Suspected Myocardial Ischemia: Results From The NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study.

Authors:  Mark Doyle; Nicole Weinberg; Gerald M Pohost; C Noel Bairey Merz; Leslee J Shaw; George Sopko; Anthon Fuisz; William J Rogers; Edward G Walsh; B Delia Johnson; Barry L Sharaf; Carl J Pepine; Sunil Mankad; Steven E Reis; Geetha Rayarao; Diane A Vido; Vera Bittner; Lindsey Tauxe; Marian B Olson; Sheryl F Kelsey; Robert Ww Biederman
Journal:  Cardiovasc Diagn Ther       Date:  2013-06

5.  A new cardiac variable identified?

Authors:  Mark Doyle
Journal:  Cardiovasc Diagn Ther       Date:  2013-09

6.  Cardiac magnetic resonance imaging myocardial perfusion reserve index assessment in women with microvascular coronary dysfunction and reference controls.

Authors:  Chrisandra L Shufelt; Louise E J Thomson; Pavel Goykhman; Megha Agarwal; Puja K Mehta; Tara Sedlak; Ning Li; Edward Gill; Bruce Samuels; Babak Azabal; Saibal Kar; Kamlesh Kothawade; Margo Minissian; Piotr Slomka; Daniel S Berman; C Noel Bairey Merz
Journal:  Cardiovasc Diagn Ther       Date:  2013-09

7.  Cardiac risk factors and myocardial perfusion reserve in women with microvascular coronary dysfunction.

Authors:  Megha Agarwal; Chrisandra Shufelt; Puja K Mehta; Edward Gill; Daniel S Berman; Debiao Li; Behzad Sharif; Ning Li; C Noel Bairey Merz; Louise E J Thomson
Journal:  Cardiovasc Diagn Ther       Date:  2013-09

8.  Five-Year Follow-Up of Coronary Microvascular Dysfunction and Coronary Artery Disease in Systemic Lupus Erythematosus: Results From a Community-Based Lupus Cohort.

Authors:  Vaneet K Sandhu; Janet Wei; Louise E J Thomson; Daniel S Berman; Jay Schapira; Daniel Wallace; Michael H Weisman; C Noel Bairey Merz; Mariko L Ishimori
Journal:  Arthritis Care Res (Hoboken)       Date:  2020-06-04       Impact factor: 4.794

9.  Aortic flow conditions predict ejection efficiency in the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE).

Authors:  Mark Doyle; Gerald M Pohost; C Noel Bairey Merz; Victor Farah; Leslee J Shaw; George Sopko; William J Rogers; Barry L Sharaf; Carl J Pepine; Diane V Thompson; Geetha Rayarao; Lindsey Tauxe; Sheryl F Kelsey; Robert W W Biederman
Journal:  Cardiovasc Diagn Ther       Date:  2017-06

10.  Stress Cardiac MRI in Women With Myocardial Infarction and Nonobstructive Coronary Artery Disease.

Authors:  Rina Mauricio; Monvadi B Srichai; Leon Axel; Judith S Hochman; Harmony R Reynolds
Journal:  Clin Cardiol       Date:  2016-07-26       Impact factor: 2.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.